Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Notes Payables: 2023-2024

Historic Notes Payables for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $10.2 million.

  • Zhengye Biotechnology Holding's Notes Payables fell 8.05% to $10.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $10.2 million, marking a year-over-year decrease of 8.05%. This contributed to the annual value of $10.2 million for FY2024, which is 9.75% down from last year.
  • Zhengye Biotechnology Holding's Notes Payables amounted to $10.2 million in FY2024, which was down 9.75% from $11.3 million recorded in FY2023.
  • Zhengye Biotechnology Holding's Notes Payables' 5-year high stood at $11.3 million during FY2023, with a 5-year trough of $10.2 million in FY2024.
  • For the 2-year period, Zhengye Biotechnology Holding's Notes Payables averaged around $10.7 million, with its median value being $10.7 million (2024).
  • Data for Zhengye Biotechnology Holding's Notes Payables shows a maximum YoY fell of 9.75% (in 2024) over the last 5 years.
  • Over the past 2 years, Zhengye Biotechnology Holding's Notes Payables (Yearly) stood at $11.3 million in 2023, then fell by 9.75% to $10.2 million in 2024.